Immunogenic clearance combined with PD-1 blockade elicits antitumor effect by promoting the recruitment and expansion of the effector memory-like CD8+ T cell
Immune checkpoint inhibition shows promise for cancer treatment, but only a minority of patients respond. Combination strategies have been explored to overcome this resistance. Combining immunogenic clearance using immunogenic cell death inducers with a rho kinase inhibitor enhances phagocytosis of...
Saved in:
Main Authors: | Seong A Kim, Seohyun Kim, Yeonsun Hong, Yoonjeong Choi, Yeji Lee, Minsu Kwon, Seung-Yoon Park, Cherlhyun Jeong, Gi-Hoon Nam, Rafael T. Han, In-San Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Translational Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S193652332400336X |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Regulatory T cells in immune checkpoint blockade antitumor therapy
by: An Zhang, et al.
Published: (2024-11-01) -
Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy
by: Xia Liu, et al.
Published: (2022-10-01) -
Immunogenic dying cells elicit potent anti-tumor T cell immunity against lung metastasis and tumorigenesis
by: Min Hu, et al.
Published: (2025-01-01) -
Preventative Cancer Vaccine-Elicited Human Anti-MUC1 Antibodies Have Multiple Effector Functions
by: Michelle L. McKeague, et al.
Published: (2024-10-01) -
Dual CD47 and PD‐L1 blockade elicits anti‐tumor immunity by intratumoral CD8+ T cells
by: Susan N Christo, et al.
Published: (2024-01-01)